Target intelligence / Profile preview

E3 ubiquitin-protein ligase RNF8 (RNF8)

Target
RNF8
Molecular classification
E3 ubiquitin ligase, Enzyme, RING finger protein, Chromatin regulator, DNA damage response factor
01

Overview

E3 ubiquitin-protein ligase RNF8 (RNF8) is an enzyme widely recognized for its critical role in the DNA damage response, acting primarily as a signal transducer in the repair of DNA double-strand breaks (DSBs). RNF8 contains a forkhead-associated (FHA) domain for protein-protein interactions and a RING finger motif that confers ubiquitin ligase activity. It operates by catalyzing the ubiquitination of histones (notably H2A and H2AX) at DNA damage sites, promoting the recruitment of downstream repair proteins (such as BRCA1 and 53BP1) and facilitating chromatin remodeling necessary for efficient repair through homologous recombination and non-homologous end joining pathways[1][3][5][6]. Beyond DNA repair, RNF8 participates in telomere maintenance, cell cycle progression, and transcriptional regulation. Disruption or deficiency of RNF8 causes genomic instability and predisposes to spontaneous tumorigenesis in mouse models and is implicated in human cancer progression and metastasis, partly by influencing transcription factors that contribute to epithelial-mesenchymal transition[1][3][4]. While considered a potential therapeutic target, no direct drugs or inhibitors are clinically validated, but its activity is under investigation, particularly in cancer and inflammatory processes[2][3][4][6].

Other names
RNF8RING finger protein 8KIAA0646hRNF8C3HC4-type zinc finger proteinUBC13/UEV-interacting ring finger proteinRING-type E3 ubiquitin transferase RNF8
02

Mechanism of action

Modulation of RNF8 (theoretically or in preclinical studies) would alter DNA repair capacity, histone ubiquitination, chromatin remodeling, and the recruitment of DNA repair complexes.

03

Biological functions

DNA double-strand break (DSB) signal transductionDNA damage response/repair (homologous recombination, non-homologous end joining)Histone ubiquitination and chromatin remodelingCell cycle regulationTelomere protectionTranscriptional regulation
04

Disease associations

Cancer (tumorigenesis, cancer progression, genomic instability, metastasis)Inflammation (chronic inflammation suggested as possible intervention area)Other (genomic instability disorders due to defective DNA repair)
05

Safety considerations

Modulating RNF8 could impact genomic stability and increase cancer risk or progression due to impaired DNA repair.Potential for broad effects on cell viability because RNF8 functions in fundamental repair and cell cycle pathways.
06

Interacting drugs

None specifically approved or clinically validated as direct RNF8 inhibitors or modulators.
07

Biomarkers

RNF8 expression or activity is reported as a potential biomarker for genomic instability and cancer prognosis, but there are no clinically validated biomarkers for patient selection specifically targeting RNF8 documented in current sources.

Beyond the preview

Go deeper on E3 ubiquitin-protein ligase RNF8 (RNF8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on E3 ubiquitin-protein ligase RNF8 (RNF8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call